Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Cost-Effectiveness of Eltrombopag Plus Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone in Adults with Severe Aplastic Anemia in the United States

Kunal C Potnis, Satoko Ito, Kishan Patel, Rory M. Shallis, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez, Scott F Huntington, Maximilian Stahl, Amer M. Zeidan, Jan Philipp Bewersdorf, George Goshua

Blood (2024) 144 (Supplement 1): 3644.

https://doi.org/10.1182/blood-2024-204312

Published: 2024

Journal Articles

Cost-Effectiveness of Allogeneic Hematopoietic Stem Cell Transplantation Versus Consolidation Chemotherapy for Patients with Intermediate Risk Acute Myeloid Leukemia

Abdulrahman Alhajahjeh, Kishan Patel, Rory M. Shallis, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez, Scott F Huntington, Maximilian Stahl, Amer M. Zeidan, George Goshua, Jan Philipp Bewersdorf

Blood (2024) 144 (Supplement 1): 788.

https://doi.org/10.1182/blood-2024-201535

Published: 2024

Journal Articles

Prevalence Trend and Predictors of Clostridium Difficile Infection in Sickle Cell Disease Patients

Siddharth Bhesania, Ivan Cancarevic, Kishan Patel, BS, Madiha Zeeshan, Renu Bhandari, Pritika Manaktala, MD, Alena Varantsova, DO, Janki Bhesania, MD, Nima Ghalehsari, MD, Shobha Mandal, MD, Achint Patel, MD MPH, Sonal Paul, MD, Parag Mehta, MD, Eshan Patel, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-141717

Published: 2020

Journal Articles

Cost-Effectiveness of Once-Weekly Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Twice-Weekly Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma

Kishan Patel, BS, Terri L. Parker, MD, Mengyang Di, MD PhD, Noffar Bar, MD, Scott F. Huntington, MD MPH, Smith Giri, MDMS

Blood (2020) 136 (Supplement 1): 51–52.

https://doi.org/10.1182/blood-2020-141972

Published: 2020

Journal Articles

Combinational Therapy of Lenalidomide with Activin A Neutralizing Antibody; Preclinical Rationale for a Novel Anti-Myeloma Strategy

Tyler Scullen, Sonia Vallet, Loredana Santo, Mariateresa Fulciniti, PhD, Homare Eda, Diana D. Cirstea, MD, Kishan Patel, Andrew Yee, Anuj Mahindra, MD, Noopur Raje, MD

Blood (2012) 120 (21): 1871.

https://doi.org/10.1182/blood.V120.21.1871.1871

Published: 2012

Journal Articles

AT9283, a Small Molecule Multi-Targeted Kinase Inhibitor with Potent Activity Against Aurora Kinase and STAT3 In Combination with Lenalidomide Results In Synergistic Anti-Myeloma Activity

Loredana Santo, MD, Teru Hideshima, MD, PhD, Diana Cirstea, MD, Madhavi L Bandi, PhD, Erik A Nelson, PhD, Hiroshi Ikeda, MD, Sonia Vallet, MD, Samantha Pozzi, MD, Kishan Patel, Gullu Gorgun, PhD, Naoya Mimura, MD, Claire Fabre, MD, Yiguo Hu, PhD, Dharminder Chauhan, PhD, Matthew S Squires, PhD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Noopur Raje, MD

Blood (2010) 116 (21): 2994.

https://doi.org/10.1182/blood.V116.21.2994.2994

Published: 2010

Journal Articles

Selective Inhibition of HDAC6 with a New Prototype Inhibitor (ACY-1215) Overcomes Bortezomib Resistance In Multiple Myeloma (MM)

Loredana Santo, MD, Teru Hideshima, MD, PhD, Andrew L. Kung, MD, PhD, Matthew Jarpe, PhD, Diana Cirstea, M.D., Kishan Patel, Samantha Pozzi, MD, Jen C. Tseng, PhD, Scott J Rodig, James Bradner, M.D., Kenneth C. Anderson, MD, Simon Jones, PhD, Noopur Raje, MD

Blood (2010) 116 (21): 2997.

https://doi.org/10.1182/blood.V116.21.2997.2997

Published: 2010

Journal Articles

CYC065, a Potent Derivative of Seliciclib Is Active In Multiple Myeloma In Preclinical Studies

Samantha Pozzi, MD, Diana Cirstea, M.D., Loredana Santo, MD, Doris M Nabikejje, Kishan Patel, Kathryn M Luly, Gaurav Gharti-Chhetry, Sonia Vallet, MD, Homare Eda, MD, PhD, Teru Hideshima, MD, Simon R Green, Kenneth C. Anderson, MD, David T. Scadden, MD, Noopur Raje, MD

Blood (2010) 116 (21): 2999.

https://doi.org/10.1182/blood.V116.21.2999.2999

Published: 2010

Journal Articles

Disruption of DEPTOR/mTORC1/mTORC2 Signaling Cascade Using a Novel Selective mTOR Kinase Inhibitor AZD8055 Results In Growth Arrest and Apoptosis In Multiple Myeloma Cells

Diana Cirstea, Teru Hideshima, Loredana Santo, Samantha Pozzi, Sonia Vallet, Kishan Patel, Gullu Gorgun, Yiguo Hu, Sylvie M Guichard, Anuj Mahindra, Kenneth C. Anderson, Noopur Raje

Blood (2010) 116 (21): 791.

https://doi.org/10.1182/blood.V116.21.791.791

Published: 2010

Journal Articles

Molecular Profiling of Extramedullary and Medullary Plasmacytomas Compared to Multiple Myeloma

Anuj Mahindra, MD, Samir B. Amin, MBBS, Aliyah R. Sohani, MD, Gabriela Motyckova, MD, PhD, Kishan Patel, Sonia Vallet, MD, Samantha Pozzi, Loredana Santo, Diana Cirstea, M.D., Christiana E. Toomey, James S. Michaelson, PhD, Ephraim P. Hochberg, MD, Paola Dal Cin, PhD, Scott J Rodig, Teru Hideshima, Kenneth C. Anderson, Nikhil C. Munshi, MD, Noopur Raje, MD

Blood (2010) 116 (21): 4042.

https://doi.org/10.1182/blood.V116.21.4042.4042

Published: 2010

Journal Articles

Lenalidomide In Combination with the Activin Receptor Type II Murine Fc Protein RAP-011: Preclinical Rationale for a Novel Anti-Myeloma Strategy

Sonia Vallet, MD, Kishan Patel, Diana Cirstea, MD, Katie Luly, Samantha Pozzi, MD, Loredana Santo, MD, Homare Eda, MD, Jasbir Seehra, Anuj Mahindra, MD, David T. Scadden, MD, Noopur Raje, MD

Blood (2010) 116 (21): 4075.

https://doi.org/10.1182/blood.V116.21.4075.4075

Published: 2010

Journal Articles

Molecular Sequaele of Activin A-Dependent Osteoblast Inhibition in Myeloma.

Blood (2009) 114 (22): 1789.

https://doi.org/10.1182/blood.V114.22.1789.1789

Published: 2009

Journal Articles

AT9283, a Small Molecule Multi-Targeted Kinase Inhibitor Induces Antimyeloma Activity Via Potent Aurora Kinase and STAT3 Inhibition.

Loredana Santo, M.D., Teru Hideshima, MD., Ph.D., Erik A. Nelson, Ph.D, Diana Cirstea, MD, Madhavi Bandi, Ph.D, Hiroshi Ikeda, MD, PhD, Gullu Gorgun, PhD, Sonia Vallet, MD., Samantha Pozzi, MD, Giulia Perrone, MD, Kishan Patel, Yiguo Hu, Ph.D, Matthew S Squires, Murray Yule, Elisabetta Calabrese, MD., Dharminder Chauhan, Ph.D, Nikhil C. Munshi, Kenneth C. Anderson, MD, Noopur Raje, MD.

Blood (2009) 114 (22): 3833.

https://doi.org/10.1182/blood.V114.22.3833.3833

Published: 2009

Journal Articles

Overcoming p53 Loss with a Multi-Targeted Small Molecule Inhibitor in Multiple Myeloma.

Diana Cirstea, MD, Teru Hideshima, MD, PhD, Loredana Santo, MD, Sonia Vallet, MD, Samantha Pozzi, MD, Kishan Patel, Hiroshi Ikeda, MD, PhD, Hannes Loferer, PhD, Giulia Perrone, MD, Gullu Gorgun, PhD, Yiguo Hu, MD, PhD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Noopur Raje, MD

Blood (2009) 114 (22): 4915.

https://doi.org/10.1182/blood.V114.22.4915.4915

Published: 2009

Journal Articles

CCL3 Impairs Osteoblast Function Via Downregulation of Osteocalcin.

Sonia Vallet, MD., Kishan Patel, Nileshwari Vaghela, Mariateresa Fulciniti, PhD, Petter Veiby, Teru Hideshima, M.D., Ph.D., Samantha Pozzi, MD, Loredana Santo, MD, Siddhartha Mukherjee, M.D., Diana Cirstea, MD, David T Scadden, MD, Kenneth C. Anderson, MD, Noopur Raje, MD.

Blood (2009) 114 (22): 739.

https://doi.org/10.1182/blood.V114.22.739.739

Published: 2009

Journal Articles

Molecular Profiling of Extramedullary and Medullary Plasmacytomas.

Anuj Mahindra, MD, Samir B Amin, MBBS, Gabriela Motyckova, MD, PhD, Aliyah R. Sohani, MD, Kishan Patel, Sonia Vallet, MD., Gaurav Chetri, Adam Ackerman, Samantha Pozzi, MD, Loredana Santo, MD, Diana Cirstea, MD, Christiana E. Toomey, Ephraim P. Hochberg, MD, Paola Dal Cin, Teru Hideshima, MD, PhD, Kenneth C. Anderson, MD, Nikhil Munshi, Noopur Raje, MD

Blood (2009) 114 (22): 1806.

https://doi.org/10.1182/blood.V114.22.1806.1806

Published: 2009

NARROW

Cost-Effectiveness of Eltrombopag Plus Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone in Adults with Severe Aplastic Anemia in the United States

Cost-Effectiveness of Allogeneic Hematopoietic Stem Cell Transplantation Versus Consolidation Chemotherapy for Patients with Intermediate Risk Acute Myeloid Leukemia

Prevalence Trend and Predictors of Clostridium Difficile Infection in Sickle Cell Disease Patients

Cost-Effectiveness of Once-Weekly Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Twice-Weekly Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma

Combinational Therapy of Lenalidomide with Activin A Neutralizing Antibody; Preclinical Rationale for a Novel Anti-Myeloma Strategy

AT9283, a Small Molecule Multi-Targeted Kinase Inhibitor with Potent Activity Against Aurora Kinase and STAT3 In Combination with Lenalidomide Results In Synergistic Anti-Myeloma Activity

Selective Inhibition of HDAC6 with a New Prototype Inhibitor (ACY-1215) Overcomes Bortezomib Resistance In Multiple Myeloma (MM)

CYC065, a Potent Derivative of Seliciclib Is Active In Multiple Myeloma In Preclinical Studies

Disruption of DEPTOR/mTORC1/mTORC2 Signaling Cascade Using a Novel Selective mTOR Kinase Inhibitor AZD8055 Results In Growth Arrest and Apoptosis In Multiple Myeloma Cells

Molecular Profiling of Extramedullary and Medullary Plasmacytomas Compared to Multiple Myeloma

Lenalidomide In Combination with the Activin Receptor Type II Murine Fc Protein RAP-011: Preclinical Rationale for a Novel Anti-Myeloma Strategy

Molecular Sequaele of Activin A-Dependent Osteoblast Inhibition in Myeloma.

AT9283, a Small Molecule Multi-Targeted Kinase Inhibitor Induces Antimyeloma Activity Via Potent Aurora Kinase and STAT3 Inhibition.

Overcoming p53 Loss with a Multi-Targeted Small Molecule Inhibitor in Multiple Myeloma.

CCL3 Impairs Osteoblast Function Via Downregulation of Osteocalcin.

Molecular Profiling of Extramedullary and Medullary Plasmacytomas.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only